The role of complement in the pathogenesis of experimental allergic encephalomyelitisLININGTON, C; MORGAN, B. P; SCOLDING, N. J et al.Brain. 1989, Vol 112, Num 4, pp 895-911, issn 0006-8950, 17 p.Article

Glucocorticoids and experimental allergic encephalomyelitis : nonspecific versus specific immunomodulation of autoimmunityTEITELBAUM, D.Israel journal of medical sciences. 1991, Vol 27, Num 7, pp 400-402, issn 0021-2180Article

Suppression of experimental allergic encephalomyelitis by the encephalitogenic peptide, in solution or bound to liposomesAVRILIONIS, K; BOGGS, J. M.Journal of neuroimmunology. 1991, Vol 35, Num 1-3, pp 201-210, issn 0165-5728Article

Etude expérimentale comparative et efficacité de deux procédés de vaccination contre l'encéphalomyelite humaine aigueIGNAT'EV, G. M; GRINBENCHA, S. V; VOROB'EVA, M.S et al.Voprosy virusologii. 1988, Vol 33, Num 2, pp 232-235, issn 0507-4088Article

Activité antivirale de l'ARN dc de levure dans l'infection expérimentale par le virus de l'encéphalomyélite aiguë humaineIGNAT'EV, G. M; GRIBENCHA, S. V; TAZULAKHOVA, EH. B et al.Voprosy virusologii. 1988, Vol 33, Num 2, pp 251-253, issn 0507-4088Article

Relapsing autoimmune demyelination : a role for vascular addressinsCANNELLA, B; CROSS, A. H; RAINE, C. S et al.Journal of neuroimmunology. 1991, Vol 35, Num 1-3, pp 295-300, issn 0165-5728Article

Development of experimental allergic encephalomyelitis during steroid administration : outcome of neurological immune-mediated disorders under immunosuppressive therapySTEINER, I; BRENNER, T; MIZRACHI-KOL, R et al.Israel journal of medical sciences. 1991, Vol 27, Num 7, pp 365-368, issn 0021-2180Article

The demyelinating potential of antibodies to myelin oligodendrocyte glycoprotein is related to their ability to fix complementPIDDLESDEN, S. J; LASSMANN, H; ZIMPRICH, F et al.The American journal of pathology. 1993, Vol 143, Num 2, pp 555-564, issn 0002-9440Article

Distinguishing acyclovir neurotoxicity from encephalomyelitisRASHIQ, S; BRIEWA, L; MOONEY, M et al.Journal of internal medicine. 1993, Vol 234, Num 5, pp 507-511, issn 0954-6820Article

Microparticles bearing encephalitogenic peptides induce T-cell tolerance and ameliorate experimental autoimmune encephalomyelitisGETTS, Daniel R; MARTIN, Aaron J; SHEA, Lonnie D et al.Nature biotechnology (Print). 2012, Vol 30, Num 12, pp 1217-1224, issn 1087-0156, 8 p.Article

Vaccination of patients with encephalomyelitis disseminataQUAST, U; HERDER, C; ZWISLER, O et al.Vaccine. 1991, Vol 9, Num 4, pp 228-230, issn 0264-410X, 3 p.Article

Tolerance and suppressor mechanisms in experimental autoimmune encephalomyelitis : implications for immunotherapy of human autoimmune diseasesMILLER, A; HAFLER, D. A; WEINER, H. L et al.The FASEB journal. 1991, Vol 5, Num 11, pp 2560-2566, issn 0892-6638Article

Post-infectious and post-vaccinal disorders of the central nervous systemGRIFFIN, D. E.Immunology and allergy clinics of North America. 1988, Vol 8, Num 2, pp 239-249, issn 0889-8561Article

Viliuisk encephalomyelitis in the Iakut people of SiberiaGOLDFARB, L. G; GAJDUSEK, D. C.Brain. 1992, Vol 115, pp 961-978, issn 0006-8950, 4Article

Kernspintomographisches Erscheinungsbild der Encephalomyelitis disseminata in Abhängigkeit von der klinischen Diagnosestellung = Imagerie RMN d'une encéphalomyélite disséminée et ses relations avec le diagnostic clinique = The MRI appearance of disseminated encephalomyelitis and its relationship to clinical diagnosisBAUER, W. M; REICHEL, M; SIGEL, K et al.RöFo. Fortschritte auf dem Gebiete der Röntgenstrahlen und der Nuklearmedizin. 1988, Vol 148, Num 4, pp 403-407, issn 0340-1618Article

Alkyllysophospholipid prevents induction of experimental allergic encephalomyelitisKLEIN-FRANKE, A; MUNDER, P. G.Journal of autoimmunity (Print). 1992, Vol 5, Num 1, pp 83-91, issn 0896-8411Article

Multiple slerosis and zoster encephalomyelitis : a probable common etiopathogenesisVIEL, R.Advances in experimental medicine and biology. 1989, Vol 257, pp 289-291, issn 0065-2598, 3 p.Conference Paper

Antigen-specific therapy of experimental allergic encephalomyelitis by soluble class II major histocompatibility complex-peptide complexesSHARMA, S. D; NAG, B; XIAO-MIN SU et al.Proceedings of the National Academy of Sciences of the United States of America. 1991, Vol 88, Num 24, pp 11465-11469, issn 0027-8424Article

Acute disseminated encephalomyelitis as a complication of treatment with goldCOHEN, M; DAY, C. P; DAY, J. L et al.British medical journal (1857). 1985, Vol 290, Num 6476, pp 1179-1180, issn 0007-1447Article

The effect of sensitization of pregnant Lewis rats with encephalitogen on the subsequent susceptibility of their offspring to allergic encephalomyelitisMERTIN, L. A; SLJIVIC, V; RUMJANEK, V. M et al.Immunology (Oxford). 1985, Vol 54, Num 2, pp 381-388, issn 0019-2805Article

Astrocytes support mast cell viability in vitrolSEELDRAYERS, P. A; LEVIN, L. A; JOHNSON, D et al.Journal of neuroimmunology. 1992, Vol 36, Num 2-3, pp 239-243, issn 0165-5728Article

Dissociation between histological and clinical signs of experimental auto-immune encephalomyelitisKALLEN, B; NILSSON, O.Acta pathologica, microbiologica et immunologica Scandinavica. Section A. Pathology. 1986, Vol 94, Num 2, pp 159-164, issn 0108-0164Article

Cyclosporin A treatment of an induced attack in a chronic relapsin model of experimental allergic encephalomyelitisSCHULLER-LEVIS, G. B; KOZLOWSKI, P. B; WISNIEWSKI, H. M et al.Clinical immunology and immunopathology (Print). 1986, Vol 40, Num 2, pp 244-252, issn 0090-1229Article

Mechanism of Theiler's virus-induced demyelination in nude miceROSENTHAL, A; FUJINAMI, R. S; LAMPERT, P. W et al.Laboratory investigation. 1986, Vol 54, Num 5, pp 515-522, issn 0023-6837Article

Suppression of experimental allergic encephalomyelitis by mitoxantroneRIDGE, S. C; SLOBODA, A. E; MCREYNOLDS, R. A et al.Clinical immunology and immunopathology (Print). 1985, Vol 35, Num 1, pp 35-42, issn 0090-1229Article